Antiviral Drug ‘Tamiflu’ Found To Be Effective Against H1N1, Study Reports

News outlets report on a new study that finds the antiviral drug Tamiflu to be effective against H1N1 flu.

Reuters: Roche-backed study finds Tamiflu saved lives in flu pandemic
“Using Roche’s medicine Tamiflu saved lives during the H1N1 swine flu pandemic four years ago, according to a new scientific study published on Wednesday…” (Hirschler, 3/18).

OnMedica: Tamiflu reduced risk of death in H1N1 influenza pandemic
“Adults hospitalized with H1N1 influenza during the 2009-2010 pandemic were 25 per cent less likely to die from the disease if they were given antiviral drugs called neuraminidase inhibitors such as Tamiflu, according to a large meta-analysis published in The Lancet Respiratory Medicine journal…” (Torjesen, 3/19).

HealthDay: Tamiflu Saved Lives During Swine Flu Pandemic, Study Confirms
“The antiviral drug Tamiflu reduced the risk of death by 25 percent among adults hospitalized during the 2009 H1N1 swine flu pandemic, according to a new review. Also, antiviral treatment within 48 hours of developing flu symptoms halved the risk of death compared with starting treatment later or receiving no treatment…” (Preidt, 3/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.